A medical insight in Michelangelo's David, 'hiding in plain sight'
Michelangelo's David is perhaps the world's most famous statue, gazed upon by millions over centuries.
Dec 26, 2019
3
1935
Michelangelo's David is perhaps the world's most famous statue, gazed upon by millions over centuries.
Dec 26, 2019
3
1935
Patients who were transplanted with hearts from hepatitis C-positive donors had comparable outcomes after one year to patients who received hearts from donors that didn't have the disease, according to a Vanderbilt University ...
Dec 20, 2019
0
1
(HealthDay)—Racial differences in disease expression and adverse clinical outcomes exist between black and white patients with hypertrophic cardiomyopathy, according to a study published online Dec. 4 in JAMA Cardiology.
Dec 5, 2019
0
1
Future cardiac outcomes can be predicted by signs of cardiac stress that appear in the blood in response to exercise, Emory cardiologists report.
Dec 4, 2019
0
81
Atrial fibrillation, also known as AFib, is the most common type of irregular heartbeat, and it is associated with increased mortality. While researchers have identified a causal link between obesity and AFib, the underlying ...
Nov 27, 2019
0
9
A new Yale study shows that some patients being treated for severe heart failure with a battery-operated pump saw significant improvement after additionally using neurohormonal blockade (NHB) drug therapy.
Nov 19, 2019
0
53
The study, Lowlands Saves Lives, compared the effect of twenty minutes of CPR training by a certified trainer with a training session of the same duration using a free downloadable virtual reality (VR) app (created by Lifesaver, ...
Nov 18, 2019
0
2
(HealthDay)—From 2011 to 2017, the age-adjusted mortality rate decreased for heart disease, but the number of heart disease deaths increased, according to a study published online Oct. 30 in JAMA Cardiology.
Oct 30, 2019
0
1
(HealthDay)—A substantial proportion of cases of cardiovascular disease (CVD) among black individuals are associated with hypertension, according to a study published online Oct. 23 in JAMA Cardiology.
Oct 25, 2019
0
2
In the last five years, the landscape of type 2 diabetes treatment has changed dramatically. Two new classes of drugs—SGLT2 inhibitors and GLP-1 receptor agonists—have been shown to prevent some of the most serious diabetes ...
Oct 23, 2019
0
2